Description: U.S. population death statistics and trends often occupy COVID-19 briefings and daily headlines. There are also publicly available mortality data sources for actuaries and others to perform their own analysis. Yet industry studies examining the impact of COVID-19 on insured populations are in their infancy. In this webcast, presenters will provide insights into how the life insured population is faring during COVID-19 by discussing the findings from two recent SOA research initiatives. LIMRA, RGA Reinsurance, the Society of Actuaries and TAI have collaborated on an effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA has surveyed insurers to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic and comparing them to pre-pandemic mortality levels.

Description: The SOA, with SCOR as the researcher, completed an experience study of post-level term (PLT) lapse and mortality. In the first part of this session, the presenters will cover the key findings of the traditional analysis regarding the shock lapse, the PLT lapse and mortality experience. The remainder of the session will focus on the results of the predictive modeling, which will provide further insights into policyholder behavior in the post-level term period.

Description: Universal Life with Secondary Guarantees (ULSG) was first introduced in the late 1990's as low-cost, long-term death benefit protection. As this business ages, writers are experiencing pressured earnings from emerging experience, secondary markets for insurance products and low interest rates. In response, writers are sharpening their pencils on experience analysis and risk management with an eye for opportunities to increase the performance of their blocks.

Description: 2021 ImpACT Conference - Session 3D: Individual Life Experience: Committee, Contest, COVID-19 and Data Update 10.26.21 Recording

Description: For actuaries interested in term life insurance, add this webcast to your calendar. Our panel of experts will discuss term life insurance from the following perspectives: Pricing Product development Reserving Risk management They will also discuss exploring data visualizations using Tableau.

Description: After a sustained period of mortality improvement, U.S. population mortality improvement has stagnated in recent years. The presenters will discuss mortality improvement trends in the U.S. population and the causes of death contributing to these trends. U.S. population cause of death trends will be analyzed and compared to trends in the insured population. Mortality rates for major causes of death will be compared between the U.S. population and the insured population. In addition, assumption setting for both older age and later duration mortality as well as mortality improvement will be covered.

Description: Are Accelerated Underwriting (AU) programs performing as expected? As mortality experience will (hopefully) be slow to emerge, it is pivotal that we look at alternative methods of monitoring early performance. From random hold outs, to post-issue APS's, and post-issue prescription profiles, explore popular monitoring techniques and lessons learned so far. Focus on confusion matrices that provide an early indication of mortality slippage relative to fluid-based underwriting decisions. Finally, explore statistical methods to determine what constitutes credibility and identify opportunities to think about mortality slippage more robustly.

Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.

Description: SARS-CoV2 will impact our post-pandemic future. Morbidity more than mortality will impact the life and health business in the mid-term. But how does this temporary disruption in health care elicit long-tail implications on other common diseases and changes in lifestyles? Find out how mid-term pricing could be affected using one case scenario and also show how mental health will particularly shape the post-pandemic future (individually and societal), not only due to long COVID. Review the experience of the insured policies and discuss future ideas for COVID-19 research at the Society of Actuaries Research Institute. Consider recent causes of death studies, as well as reported claims analyses to help expedite the analysis of recent experience. Join us where experts from both the medical and actuarial disciplines join forces to discuss this important topic.

Description: In this session, the latest research from the Society of Actuaries (SOA) Research Institute examining the impact of COVID-19 on mortality is highlighted. Included will be insights into how the life insured population is faring during COVID-19. Among the studies presented is an effort underway to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA Research Institute surveyed insurers to gather a high-level view of U.S. group term life insurance mortality results during the COVID-19 pandemic and comparing them to pre-pandemic mortality levels. By attending this session, you will:•Understand SOA Research Institute activities on COVID-19's influence on mortality•Apply research results and insights presented in daily work.